← Eichor
Condition: Empagliflozin In Cardiorenal Syndrome Type 1 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Empagliflozin In Cardiorenal Syndrome Type 1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1
Phase 2/Phase 3 · 1 location(s) · Chulalongkorn University · NCT06030843
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.